Sara Reifman, MA CCC-SLP | |
611 Korte Way, Longmont, CO 80501-6366 | |
(303) 776-7417 | |
Not Available |
Full Name | Sara Reifman |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 611 Korte Way, Longmont, Colorado |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1174955561 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 1405 (Colorado) | Primary |
Mailing Address | Practice Location Address |
---|---|
Sara Reifman, MA CCC-SLP 1444 Folsom St, B211, Boulder, CO 80302-6879 Ph: () - | Sara Reifman, MA CCC-SLP 611 Korte Way, Longmont, CO 80501-6366 Ph: (303) 776-7417 |
News Archive
Fibromyalgia (FM) is a debilitating condition affecting 11 million individuals in the US alone. FM carries an annual direct cost for care of more than $20 billion and drug therapies are generally only 30% effective in relieving symptoms and 20% effective in improving function. Standard care currently includes medications accompanied by exercise and coping skills approaches. In a study published in the November 2010 issue of PAIN, researchers report patients participating in a "Yoga of Awareness" program showed significantly greater improvement in FM symptoms and functioning compared to patients on a standard FM care program.
An experimental drug for Hodgkin's lymphoma, studied at the University of Alabama at Birmingham, showed beneficial effects in stopping tumor growth with moderate side-effects, according to findings published Thursday in the New England Journal of Medicine.
Women who were born preterm have a higher risk of giving birth to preterm children, according to a study, published in the journal Obstetrics & Gynecology, from researchers of the CHU Sainte-Justine and the University of Montreal.
Luna Innovations Incorporated (NASDAQ:LUNA), a company focusing on sensing & instrumentation and pharmaceutical nanomedicines, today announced that the Company has received a letter from The NASDAQ Stock Market indicating that because the bid price of the Company's common stock closed below the minimum $1.00 per share threshold set forth in NASDAQ Listing Rule 5550(a)(2) for the prior 30 consecutive business days, the Company has been provided 180 calendar days, or until March 15, 2010, to regain compliance with the minimum bid price requirement.
Telephoning and writing to individuals who have not filled their new prescription for statin medication significantly improves rates of prescription uptake, show US study results.
› Verified 8 days ago
Scarlet Larkin Inc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 519 Emery St, Longmont, CO 80501 Phone: 303-702-0091 Fax: 303-702-0108 | |
Amy Hamilton Thrasher, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 611 Korte Way, Longmont, CO 80501 Phone: 303-776-7417 | |
Gretel Lys Bey, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 163 Donovan Ct, Longmont, CO 80501 Phone: 303-682-2645 | |
Chad Hunter Grossman, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 205 Ken Pratt Blvd Ste 120-1005, Longmont, CO 80501 Phone: 215-262-6937 | |
Mrs. Shannon Leah Turley, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 700 Ken Pratt Blvd Ste 106, Longmont, CO 80501 Phone: 970-231-0745 | |
Beth Legg, M.A, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 820 Main St, Longmont, CO 80501 Phone: 303-702-7806 | |
Amanda Lopez, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 711 Darby Ct Apt 205, Longmont, CO 80501 Phone: 612-770-1709 |